ADLM 2026 final round-up

ADLM 2026 concludes with a clear focus on AI, automation, and precision diagnostics

31 Jul 2026

As ADLM 2026 draws to a close, the exhibition halls may be preparing to empty, but the conversations that defined this year's meeting are likely to have a lasting impact on laboratories around the world.

Over four days in Anaheim, laboratory professionals, clinicians, scientists, and industry leaders came together to showcase new technologies, share expertise, and discuss the challenges shaping the future of diagnostic testing.

From AI-powered workflow solutions and advanced automation platforms to next-generation molecular diagnostics and emerging sequencing technologies, the innovation on display reflected a rapidly evolving laboratory landscape.

As the event comes to an end, several key themes stand out:

Key takeaways from ADLM 2026

  • AI is no longer a future trend – Across the exhibition floor, companies demonstrated practical applications of artificial intelligence for data interpretation, workflow optimization, operational efficiency, and clinical decision support.
  • Precision diagnostics continues to accelerate – Advances in molecular diagnostics, biomarker discovery, next-generation sequencing, and personalized medicine highlighted the growing importance of delivering actionable clinical insights faster than ever before.
  • Automation remains essential – New automated workflows, connected laboratory solutions, and intelligent instrumentation showcased how laboratories are addressing staffing challenges while improving productivity and consistency.
  • Collaboration is driving innovation – Strategic partnerships, customer collaborations, and cross-industry initiatives were a common theme, reflecting a shared commitment to solving complex healthcare challenges through collective expertise.

Among the many innovations attracting attention throughout the week were new developments in molecular diagnostics from companies such as Cepheid, expanded patient-centric testing capabilities from Siemens Healthineers, advances in laboratory automation and workflow efficiency, and growing investment in technologies designed to help laboratories manage increasing testing demands with greater speed and confidence.

The human side of laboratory medicine

While much of ADLM focuses on technology, some of the most valuable insights came from the people behind it.

Conversations from the show floor continue as the SelectScience team meets with experts at ADLM 2026

Conversations from the show floor continue as the SelectScience team meets with experts at ADLM 2026

Throughout the week, the SelectScience team spoke with scientists, laboratory leaders, clinicians, and innovators from across the world. Their perspectives reinforced the realities laboratories continue to face: workforce shortages, increasing testing demands, evolving regulatory requirements, and pressure to deliver more with fewer resources.

At the same time, there was a strong sense of optimism.

Many attendees viewed the innovations on display not simply as new products, but as tools that can help laboratories deliver better healthcare, improve patient outcomes, and support scientific discovery.

That optimism, perhaps more than any individual product announcement, defined the spirit of ADLM 2026.

Looking beyond ADLM 2026

As the SelectScience team prepares to leave Anaheim, one message stands above all others: laboratory medicine is evolving rapidly, but the industry's priorities remain remarkably clear.

Laboratories are seeking technologies that help them work smarter. They are looking for solutions that improve efficiency without compromising quality. They are embracing innovation while demanding evidence, trust, and real-world impact.

ADLM 2026 demonstrated that the industry is rising to meet those expectations.

Artificial intelligence is maturing. Precision diagnostics is expanding. Automation is becoming increasingly sophisticated. Most importantly, the people driving these advances remain committed to improving healthcare through science and innovation.

The technologies unveiled this week may shape the future of laboratory medicine, but it is the collective ambition of the scientific community that will ultimately determine what comes next.

The conversations may be ending in Anaheim, but their impact is only just beginning.

By Sonia Nicholas and Olivia Long, reporting from ADLM 2026 in Anaheim, California

Tags